Cervical Stenosis and CSM
Q. What is cervical stenosis and cervical spondylotic myelopathy (CSM)?
Cervical stenosis is narrowing of the spinal canal that compresses the spinal cord and/or exiting nerve roots. When caused by degenerative changes such as intervertebral disc desiccation, osteophyte formation, uncovertebral hypertrophy, thickened ligamentum flavum, or ossified posterior longitudinal ligament (OPLL), the resulting cord dysfunction is termed cervical spondylotic myelopathy (CSM). It is the most common cause of spinal cord dysfunction in adults.
Q. What is congenital cervical stenosis?
Congenital cervical stenosis (CCS) is a developmentally small canal, usually due to short pedicles and thick laminae, resulting in a uniformly narrowed spinal canal. These patients have reduced reserve space for the cord and are prone to develop myelopathy at a younger age, even after minor trauma or minimal spondylotic changes.
Q. What is the normal canal size and what is the Torg–Pavlov ratio?
On lateral radiograph or sagittal CT/MRI, normal canal AP diameter is 17–18 mm. Relative stenosis occurs at 13–17 mm, and absolute stenosis below 13 mm.
The Torg–Pavlov ratio is the ratio of spinal canal diameter to vertebral body diameter at the same level. A ratio ≥ 0.8 is normal, while < 0.7 indicates congenital stenosis.
Q. What is the pathophysiology of CSM?
CSM develops through static compression from osteophytes, OPLL, and thickened ligaments; dynamic compression during flexion-extension; and ischemic injury due to chronic microvascular compromise. Patients with congenitally narrow canals suffer these effects earlier and more severely.
Q. What are the clinical features of cervical stenosis and CSM?
Neck pain, stiffness, hand clumsiness, paresthesias, spastic gait, Lhermitte’s sign, hyperreflexia, Babinski and Hoffman signs, hand wasting, loss of vibration sense, and sphincter disturbances.
Advanced cases show quadriparesis with long-tract signs in all limbs.
Q. How will you differentiate CSM from amyotrophic lateral sclerosis (ALS) or motor neuron disease?
In CSM, both upper and lower motor neuron features occur but remain localized to the cervical and subcervical segments, often with sensory and sphincter involvement and MRI evidence of compression.
In ALS, there is widespread, asymmetric UMN and LMN involvement without sensory or sphincter symptoms, normal MRI, and a relentlessly progressive course.
Q. What is the Crandall and Batzdorf clinical classification for cervical spondylotic myelopathy (CSM)?
It categorizes CSM into five clinical syndromes based on the primary neurological presentation:
Transverse Lesion Syndrome: Global involvement across motor, sensory, and posterior column pathways (the most common pattern).
Motor System Syndrome: Predominantly corticospinal tract dysfunction, manifesting as lower extremity spasticity and upper extremity weakness, with minimal sensory changes.
Central Cord Syndrome: Upper extremity weakness and motor loss disproportionately worse than lower extremity impairment, accompanied by variable sensory loss.
Brachial-Amyotrophic Syndrome: Marked lower motor neuron upper extremity weakness and rapid muscle atrophy without significant sensory deficits.
Radiculomyelopathy: Combination of upper motor neuron myelopathic signs with distinct, focal lower motor neuron root involvement.
Q. How is CSM classified based on the anatomical site of compression?
Anterior Compression: Driven by ventral pathologies such as disc herniations, disc-osteophyte complexes, or ossification of the posterior longitudinal ligament (OPLL).
Posterior Compression: Caused by dorsal structures such as hypertrophied or shingled ligamentum flavum, facet joint arthropathy, or posterior laminar infolding.
Concentric (Circumferential) Compression: Ring-like narrowing of the spinal canal from combined anterior disc-osteophyte complexes and posterior ligamentum flavum infolding.
Q. How is CSM graded according to the Nurick scale?
The Nurick scale evaluates the clinical severity of CSM based on gait impairment and functional capacity:
Grade 0: Root signs present without evidence of spinal cord involvement.
Grade I: Cord involvement present; gait is normal.
Grade II: Mild gait abnormality present; normal employment remains possible.
Grade III: Gait abnormality prevents full employment, but the patient ambulates independently.
Grade IV: Ambulation is possible only with assistance or a walker.
Grade V: Patient is chairbound or bedridden.
Q. How does the Nurick scale guide clinical management and surgical decision-making in cervical spondylotic myelopathy (CSM)?
The Nurick scale directly correlates functional gait impairment with treatment strategies, surgical urgency, and expected postoperative prognosis:
Nurick Grade 0 to I (Mild Myelopathy):
Management: Conservative management (close observation, activity modification, isometric neck exercises, and soft collar use for acute flare-ups) or selective operative intervention.
Decision Strategy: Surgery is considered if there are progressive neurological deficits, severe spinal cord signal changes on MRI (such as T2 hyperintensity), or significant pain that fails conservative therapy.
Nurick Grade II to III (Moderate Myelopathy):
Management: Surgical decompression is the standard recommendation.
Decision Strategy: Patients in these grades experience clear functional impairment but retain ambulation. Operating at this stage halts disease progression and offers the highest likelihood of significant functional recovery, as irreversible spinal cord damage is minimized.
Nurick Grade IV to V (Severe Myelopathy):
Management: Urgent or early surgical intervention.
Decision Strategy: Surgery is performed primarily to arrest further neurological deterioration, prevent total loss of independence, and relieve cord compression. However, long-standing severe cord compression (Grade V) lowers the likelihood of achieving full functional recovery due to irreversible gliosis or anterior horn cell loss.
Prognostic Value: Preoperative Nurick grade is one of the strongest independent predictors of surgical outcomes. Patients presenting with lower baseline Nurick scores (Grades I–III) demonstrate significantly higher rates of neurological improvement following surgery compared to those presenting with advanced grades (Grades IV–V).
